SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LoLoLoLita who wrote (3454)12/11/1997 11:02:00 PM
From: Zebra 365  Read Replies (1) of 23519
 
I know your post of "questions to Dr. Greco" was halfway tongue-in-cheek, but you came remarkably close to the very questions that I sent. I will post any reply.

To Sailor: Regarding production prior to approval. Yes, the plant must produce product in order to show that it meets the same standards as the original product in order to be approved. This is one reason they moved the equipment so that they would have a jump start on approval using a line that was already known to meet the standards. So they can stockpile product produced and tested in the test runs and ship it once the line is approved. Remember they only count revenues when they ship product so there may be a surge of revenue on approvals.

Zebra
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News